Types and Diagnosis of Salivary Gland Tumors - Pleomorphic adenoma - Mucoepidermoid carcinoma - Adenoid cystic carcinoma - Acinic cell carcinoma - Warthin tumor - Physical examination - Imaging tests (ultrasound, CT scan, MRI) - Fine needle aspiration cytology (FNAC) - Histopathology - Molecular testing

Treatment Options for Salivary Gland Tumors - Surgery (partial or complete removal of the tumor) - Radiation therapy - Chemotherapy - Targeted therapy - Palliative care

Prognosis and Survival Rates of Salivary Gland Tumors - Prognosis depends on the type and stage of the tumor - Five-year survival rates vary depending on the tumor type (ranging from 20% to 85%) - Factors affecting prognosis include tumor size, location, grade, and presence of metastasis - Recurrence rates vary depending on the tumor type (ranging from 10% to 80%) - Regular follow-up and monitoring are important for early detection of recurrence

Risk Factors of Salivary Gland Tumors - Radiation exposure (e.g., previous radiation therapy) - Environmental factors (e.g., exposure to certain chemicals) - Family history of salivary gland tumors - Age (most common in adults over 40) - Gender (some tumor types are more common in males)

Epidemiology of Salivary Gland Tumors - Limited knowledge of total incidence due to unrecorded benign tumors - Majority of salivary tumors are benign (65-70%) - Higher incidence of benign tumors in parotid gland (75-80%) - Submandibular gland tumors are 50% benign - Sublingual gland tumors are rare but more likely to be malignant